Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-013386
Filing Date
2016-02-16
Accepted
2016-02-16 16:47:20
Documents
1
Period of Report
2016-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4178
  Complete submission text file 0000899243-16-013386.txt   5769
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address
Grais Linda S (Reporting) CIK: 0001413306 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 161429643